Marinus Pharmaceuticals: Q1 Earnings Snapshot
Thu, May 12, 2022 4:32 PM
STATS Perform dba Automated Insights
RADNOR, Pa. (AP) _ Marinus Pharmaceuticals Inc. (MRNS) on Thursday reported a loss of $19.4 million in its first quarter.
The Radnor, Pennsylvania-based company said it had a loss of 52 cents per share.
The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 87 cents per share.
The epilepsy drug developer posted revenue of $14.2 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $2.2 million.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRNS at https://www.zacks.com/ap/MRNS